Ironwood Pharmaceuticals | Ativo Circulante

Current Assets Alterar Data
Acadia Pharmaceuticals USD 675.3M 59.17M 2024-03
Agios Pharmaceuticals USD 663.63M 170.21M 2024-03
Almirall EUR 664.1M 54.56M 2024-03
Alnylam Pharmaceuticals USD 2.99B 5.91M 2024-03
Amarin USD 687.93M 37.05M 2024-03
Ardelyx USD 257.94M 16.72M 2024-03
Astellas Pharma JPY 1.05T 66.65B 2023-12
AstraZeneca USD 25.59B 540M 2024-03
Charles River Laboratories USD 1.67B 59.53M 2024-03
Exact Sciences USD 1.12B 74.1M 2024-03
Halozyme Therapeutics USD 873.58M 127.16M 2024-03
Incyte USD 4.85B 203.69M 2024-03
Ironwood Pharmaceuticals USD 208.17M 25.11M 2024-03
MacroGenics USD 202.58M 48.76M 2024-03
Moderna USD 9.6B 725M 2024-03
Myriad Genetics USD 290.3M 23.3M 2024-03
Pacira USD 543.11M 33.12M 2024-03
PTC Therapeutics USD 1.17B 49.89M 2024-03
Sarepta Therapeutics USD 2.46B 14.02M 2024-03
Takeda JPY 2.43T 33.24B 2023-12
Ultragenyx Pharmaceutical USD 595.97M 3.22M 2024-03



Ironwood Pharmaceuticals Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.